Hold Rating on Allakos Amidst Cautious Optimism for AK006 Program
TipRanksMar 19 01:38 ET
Analysts Are Bullish on These Healthcare Stocks: Allakos (ALLK), Century Therapeutics (IPSC)
TipRanksMar 15 07:10 ET
Analysts Conflicted on These Healthcare Names: Allogene Therapeutics (ALLO), Aquestive Therapeutics (AQST) and Allakos (ALLK)
TipRanksMar 15 00:40 ET
TD Cowen Remains a Hold on Allakos (ALLK)
TipRanksMar 14 18:35 ET
Analysts' Top Healthcare Picks: KalVista Pharmaceuticals (KALV), Allakos (ALLK)
TipRanksFeb 26 16:10 ET
Allakos Analyst Ratings
BenzingaJan 17 14:15 ET
Allakos Extends Losses as Analysts Downgrade on Phase 2 Setback
Seeking AlphaJan 17 11:52 ET
JMP Securities Adjusts Allakos' Price Target to $3 From $10, Maintains Market Outperform Rating
MT NewswiresJan 17 07:22 ET
Allakos Analyst Ratings
BenzingaJan 17 05:54 ET
Analysts Offer Insights on Healthcare Companies: Allakos (ALLK) and Crinetics Pharmaceuticals (CRNX)
TipRanksDec 19, 2023 07:40 ET
Allakos Analyst Ratings
BenzingaDec 18, 2023 07:06 ET
Jefferies Assumes Allakos at Buy, Lowers Price Target of $6
BenzingaDec 8, 2023 08:59 ET
Allakos Analyst Ratings
BenzingaDec 8, 2023 08:55 ET
JMP Securities Reiterates Market Outperform on Allakos, Maintains $10 Price Target
BenzingaNov 28, 2023 12:26 ET
Allakos Analyst Ratings
BenzingaNov 28, 2023 12:24 ET
Buy Rating for Allakos: Anticipating Lirentelimab's Market Catalyst and Blockbuster Potential
TipRanksNov 28, 2023 00:45 ET
Promising Developments and Solid Financials Drive Buy Rating for Allakos: An Analysis of Lirentelimab Trials and Investment Potential
TipRanksNov 14, 2023 17:55 ET
Barclays Maintains Underweight on Allakos, Lowers Price Target to $1.5
BenzingaNov 14, 2023 07:59 ET
Allakos Analyst Ratings
BenzingaNov 14, 2023 07:56 ET
TD Cowen Reaffirms Their Hold Rating on Allakos (ALLK)
TipRanksNov 13, 2023 17:45 ET
No Data
No Data